Jump Financial’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
Other funds holding AVBP
IAM
Jump Financial's AVBP Position: Q3 2026 in Review
Jump Financial increased its ArriVent BioPharma (AVBP) stake by 173% in Q3 2026, buying an estimated $1.58M and bringing the position to 81,067 shares worth $2.45M. The position accounts for 0.02% of the portfolio, ranked #937.
Jump Financial first reported a position in AVBP in Q3 2025 and has held it in 5 quarters since. 153 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.
- Jump Financial held 81,067 shares of ArriVent BioPharma worth $2.45M as of Q3 2026.
- Jump Financial bought 51,423 ArriVent BioPharma shares in Q3 2026, an estimated $1.58M.
- ArriVent BioPharma made up 0.02% of Jump Financial's portfolio in Q3 2026, its #937 holding.
- Jump Financial first reported a position in ArriVent BioPharma in Q3 2025 and has held it in 5 quarters since.
- 153 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.
Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.